CHINA PH ARMACY Volume 33，Number 8，April 30，2022 Semimonthly Table of Contents Expert consensus on prescription review rules of proton pump inhibitors
- VernacularTitle:质子泵抑制剂审方规则专家共识
- Author:
Association PHARMACEUTICAL
1
Author Information
1. Pharmaceutical Administration Committee of Chongqing Hospital Association
- Publication Type:Journal Article
- Keywords:
proton pump inhibitor;
prescription suitability;
prescription review rules;
clinical application;
expert consensus
- From:
China Pharmacy
2022;33(8):897-910
- CountryChina
- Language:Chinese
-
Abstract:
In order to further s tandardize the clinical application of proton pump inhibitors and provide reference for prescription suitability review ，under the guidance of Guiding Principles for Clinical Use of Proton Pump Inhibitor which was promulgated by the General Office of National Health Commission of the People ’s Republic of China ，Pharmaceutical Admini- stration Committee of Chongqing Hospital Association initiates “the formulation Project on Prescription Review Rules for Proton Pump Inhibitors ”. The First Affiliated Hospital of the Army Medical University takes the lead and cooperates with clinical experts ， pharmaceutical experts and evidence-based experts from many domestic medical institutions to discuss the indications ，usage and dosage，medication for special groups and drug interactions of proton pump inhibitors ，and finally forms this consensus. The main contents of the consensus include the basic prescription review rules of omeprazole ，esmeprazole，pantoprazole，rabeprazole， lansoprazole and iprazole （including injection and oral preparations ，calculated by common name ），and 12 prescription review recommendations for some clinical applications not covered on the basic prescription review rules ，in order to provide reference for medical institutions at all levels.
